Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex®/Epidyolex® During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant First published 21/11/2023 Last updated 18/10/2024 EU PAS number:EUPAS107705 Study Planned